Global Antidiabetic Drug Sales Market Report 2018

June 2018 | 117 pages | ID: G686D4C1B43EN
QYResearch

Abstracts

This report studies the global Antidiabetic Drug market status and forecast, categorizes the global Antidiabetic Drug market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug

The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market.
Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.

The global Antidiabetic Drug market is valued at 49600 million US$ in 2017 and will reach 96700 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2018-2025.
The major players covered in this report

• Sanofi-Aventis
• Eli Lilly
• Oramed
• Takeda
• Boehringer Ingelheim
• Novo Nordisk
• Halozyme Therapeutics
• Bristol-Myers Squibb
• Pfizer
• Tonghua Dongbao
• Biocon
• Wockhardt

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Alpha-Glucosidase Inhibitors
• Biguanides, Sulphonylureas
• Glp-1 Agonist
• Meglitinides
• Dpp-4 Inhibitors
• Sglt–2
• Thiazolodinediones

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Type I Diabetes
• Type II Diabetes

The study objectives of this report are:

• To analyze and study the global Antidiabetic Drug sales, value, status (2013-2017) and forecast (2018-2025);
• To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
• Focuses on the key Antidiabetic Drug players, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antidiabetic Drug are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Antidiabetic Drug Manufacturers
Antidiabetic Drug Distributors/Traders/Wholesalers
Antidiabetic Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Antidiabetic Drug market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Antidiabetic Drug Sales Market Report 2018

1 ANTIDIABETIC DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Antidiabetic Drug
1.2 Classification of Antidiabetic Drug by Product Category
  1.2.1 Global Antidiabetic Drug Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Antidiabetic Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Alpha-Glucosidase Inhibitors
  1.2.4 Biguanides, Sulphonylureas
  1.2.5 Glp-1 Agonist
  1.2.6 Meglitinides
  1.2.7 Dpp-4 Inhibitors
  1.2.8 Sglt–2
  1.2.9 Thiazolodinediones
1.3 Global Antidiabetic Drug Market by Application/End Users
  1.3.1 Global Antidiabetic Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.1 Type I Diabetes
  1.3.2 Type II Diabetes
1.4 Global Antidiabetic Drug Market by Region
  1.4.1 Global Antidiabetic Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Antidiabetic Drug Status and Prospect (2013-2025)
  1.4.3 Europe Antidiabetic Drug Status and Prospect (2013-2025)
  1.4.4 China Antidiabetic Drug Status and Prospect (2013-2025)
  1.4.5 Japan Antidiabetic Drug Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Antidiabetic Drug Status and Prospect (2013-2025)
  1.4.7 India Antidiabetic Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Antidiabetic Drug (2013-2025)
  1.5.1 Global Antidiabetic Drug Sales and Growth Rate (2013-2025)
  1.5.2 Global Antidiabetic Drug Revenue and Growth Rate (2013-2025)

2 GLOBAL ANTIDIABETIC DRUG COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Antidiabetic Drug Market Competition by Players/Suppliers
  2.1.1 Global Antidiabetic Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Antidiabetic Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Antidiabetic Drug (Volume and Value) by Type
  2.2.1 Global Antidiabetic Drug Sales and Market Share by Type (2013-2018)
  2.2.2 Global Antidiabetic Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Antidiabetic Drug (Volume and Value) by Region
  2.3.1 Global Antidiabetic Drug Sales and Market Share by Region (2013-2018)
  2.3.2 Global Antidiabetic Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Antidiabetic Drug (Volume) by Application

3 UNITED STATES ANTIDIABETIC DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Antidiabetic Drug Sales and Value (2013-2018)
  3.1.1 United States Antidiabetic Drug Sales and Growth Rate (2013-2018)
  3.1.2 United States Antidiabetic Drug Revenue and Growth Rate (2013-2018)
  3.1.3 United States Antidiabetic Drug Sales Price Trend (2013-2018)
3.2 United States Antidiabetic Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Antidiabetic Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Antidiabetic Drug Sales Volume and Market Share by Application (2013-2018)

4 EUROPE ANTIDIABETIC DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Europe Antidiabetic Drug Sales and Value (2013-2018)
  4.1.1 Europe Antidiabetic Drug Sales and Growth Rate (2013-2018)
  4.1.2 Europe Antidiabetic Drug Revenue and Growth Rate (2013-2018)
  4.1.3 Europe Antidiabetic Drug Sales Price Trend (2013-2018)
4.2 Europe Antidiabetic Drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Antidiabetic Drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Antidiabetic Drug Sales Volume and Market Share by Application (2013-2018)

5 CHINA ANTIDIABETIC DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 China Antidiabetic Drug Sales and Value (2013-2018)
  5.1.1 China Antidiabetic Drug Sales and Growth Rate (2013-2018)
  5.1.2 China Antidiabetic Drug Revenue and Growth Rate (2013-2018)
  5.1.3 China Antidiabetic Drug Sales Price Trend (2013-2018)
5.2 China Antidiabetic Drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Antidiabetic Drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Antidiabetic Drug Sales Volume and Market Share by Application (2013-2018)

6 JAPAN ANTIDIABETIC DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Antidiabetic Drug Sales and Value (2013-2018)
  6.1.1 Japan Antidiabetic Drug Sales and Growth Rate (2013-2018)
  6.1.2 Japan Antidiabetic Drug Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Antidiabetic Drug Sales Price Trend (2013-2018)
6.2 Japan Antidiabetic Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Antidiabetic Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Antidiabetic Drug Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA ANTIDIABETIC DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Antidiabetic Drug Sales and Value (2013-2018)
  7.1.1 Southeast Asia Antidiabetic Drug Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Antidiabetic Drug Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Antidiabetic Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Antidiabetic Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Antidiabetic Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Antidiabetic Drug Sales Volume and Market Share by Application (2013-2018)

8 INDIA ANTIDIABETIC DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 India Antidiabetic Drug Sales and Value (2013-2018)
  8.1.1 India Antidiabetic Drug Sales and Growth Rate (2013-2018)
  8.1.2 India Antidiabetic Drug Revenue and Growth Rate (2013-2018)
  8.1.3 India Antidiabetic Drug Sales Price Trend (2013-2018)
8.2 India Antidiabetic Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Antidiabetic Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Antidiabetic Drug Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL ANTIDIABETIC DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Sanofi-Aventis
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Antidiabetic Drug Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Sanofi-Aventis Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Eli Lilly
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Antidiabetic Drug Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Eli Lilly Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Oramed
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Antidiabetic Drug Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Oramed Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Takeda
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Antidiabetic Drug Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Takeda Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Boehringer Ingelheim
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Antidiabetic Drug Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Boehringer Ingelheim Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Novo Nordisk
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Antidiabetic Drug Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Novo Nordisk Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Halozyme Therapeutics
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Antidiabetic Drug Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Halozyme Therapeutics Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Bristol-Myers Squibb
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Antidiabetic Drug Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Bristol-Myers Squibb Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Pfizer
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Antidiabetic Drug Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Pfizer Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 Tonghua Dongbao
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Antidiabetic Drug Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Tonghua Dongbao Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview
9.11 Biocon
9.12 Wockhardt

10 ANTIDIABETIC DRUG MAUFACTURING COST ANALYSIS

10.1 Antidiabetic Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Antidiabetic Drug
10.3 Manufacturing Process Analysis of Antidiabetic Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Antidiabetic Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antidiabetic Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL ANTIDIABETIC DRUG MARKET FORECAST (2018-2025)

14.1 Global Antidiabetic Drug Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Antidiabetic Drug Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Antidiabetic Drug Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Antidiabetic Drug Price and Trend Forecast (2018-2025)
14.2 Global Antidiabetic Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Antidiabetic Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Antidiabetic Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Antidiabetic Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 Europe Antidiabetic Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 China Antidiabetic Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Antidiabetic Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Antidiabetic Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Antidiabetic Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Antidiabetic Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Antidiabetic Drug Sales Forecast by Type (2018-2025)
  14.3.2 Global Antidiabetic Drug Revenue Forecast by Type (2018-2025)
  14.3.3 Global Antidiabetic Drug Price Forecast by Type (2018-2025)
14.4 Global Antidiabetic Drug Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antidiabetic Drug
Figure Global Antidiabetic Drug Sales Volume Comparison (K MT) by Type (2013-2025)
Figure Global Antidiabetic Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Alpha-Glucosidase Inhibitors Product Picture
Figure Biguanides, Sulphonylureas Product Picture
Figure Glp-1 Agonist Product Picture
Figure Meglitinides Product Picture
Figure Dpp-4 Inhibitors Product Picture
Figure Sglt–2 Product Picture
Figure Thiazolodinediones Product Picture
Figure Global Antidiabetic Drug Sales Comparison (K MT) by Application (2013-2025)
Figure Global Sales Market Share of Antidiabetic Drug by Application in 2017
Figure Type I Diabetes Examples
Table Key Downstream Customer in Type I Diabetes
Figure Type II Diabetes Examples
Table Key Downstream Customer in Type II Diabetes
Figure Global Antidiabetic Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Antidiabetic Drug Sales Volume (K MT) and Growth Rate (2013-2025)
Figure Global Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Antidiabetic Drug Sales Volume (K MT) (2013-2018)
Table Global Antidiabetic Drug Sales (K MT) of Key Players/Suppliers (2013-2018)
Table Global Antidiabetic Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Antidiabetic Drug Sales Share by Players/Suppliers
Figure 2017 Antidiabetic Drug Sales Share by Players/Suppliers
Figure Global Antidiabetic Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Antidiabetic Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Antidiabetic Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Antidiabetic Drug Revenue Share by Players
Table 2017 Global Antidiabetic Drug Revenue Share by Players
Table Global Antidiabetic Drug Sales (K MT) and Market Share by Type (2013-2018)
Table Global Antidiabetic Drug Sales Share (K MT) by Type (2013-2018)
Figure Sales Market Share of Antidiabetic Drug by Type (2013-2018)
Figure Global Antidiabetic Drug Sales Growth Rate by Type (2013-2018)
Table Global Antidiabetic Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Antidiabetic Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Antidiabetic Drug by Type (2013-2018)
Figure Global Antidiabetic Drug Revenue Growth Rate by Type (2013-2018)
Table Global Antidiabetic Drug Sales Volume (K MT) and Market Share by Region (2013-2018)
Table Global Antidiabetic Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Antidiabetic Drug by Region (2013-2018)
Figure Global Antidiabetic Drug Sales Growth Rate by Region in 2017
Table Global Antidiabetic Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Antidiabetic Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Antidiabetic Drug by Region (2013-2018)
Figure Global Antidiabetic Drug Revenue Growth Rate by Region in 2017
Table Global Antidiabetic Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Antidiabetic Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Antidiabetic Drug by Region (2013-2018)
Figure Global Antidiabetic Drug Revenue Market Share by Region in 2017
Table Global Antidiabetic Drug Sales Volume (K MT) and Market Share by Application (2013-2018)
Table Global Antidiabetic Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Antidiabetic Drug by Application (2013-2018)
Figure Global Antidiabetic Drug Sales Market Share by Application (2013-2018)
Figure United States Antidiabetic Drug Sales (K MT) and Growth Rate (2013-2018)
Figure United States Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Antidiabetic Drug Sales Price (USD/MT) Trend (2013-2018)
Table United States Antidiabetic Drug Sales Volume (K MT) by Players (2013-2018)
Table United States Antidiabetic Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Antidiabetic Drug Sales Volume Market Share by Players in 2017
Table United States Antidiabetic Drug Sales Volume (K MT) by Type (2013-2018)
Table United States Antidiabetic Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Antidiabetic Drug Sales Volume Market Share by Type in 2017
Table United States Antidiabetic Drug Sales Volume (K MT) by Application (2013-2018)
Table United States Antidiabetic Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Antidiabetic Drug Sales Volume Market Share by Application in 2017
Figure Europe Antidiabetic Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Europe Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Antidiabetic Drug Sales Price (USD/MT) Trend (2013-2018)
Table Europe Antidiabetic Drug Sales Volume (K MT) by Players (2013-2018)
Table Europe Antidiabetic Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Antidiabetic Drug Sales Volume Market Share by Players in 2017
Table Europe Antidiabetic Drug Sales Volume (K MT) by Type (2013-2018)
Table Europe Antidiabetic Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Antidiabetic Drug Sales Volume Market Share by Type in 2017
Table Europe Antidiabetic Drug Sales Volume (K MT) by Application (2013-2018)
Table Europe Antidiabetic Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Antidiabetic Drug Sales Volume Market Share by Application in 2017
Figure China Antidiabetic Drug Sales (K MT) and Growth Rate (2013-2018)
Figure China Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Antidiabetic Drug Sales Price (USD/MT) Trend (2013-2018)
Table China Antidiabetic Drug Sales Volume (K MT) by Players (2013-2018)
Table China Antidiabetic Drug Sales Volume Market Share by Players (2013-2018)
Figure China Antidiabetic Drug Sales Volume Market Share by Players in 2017
Table China Antidiabetic Drug Sales Volume (K MT) by Type (2013-2018)
Table China Antidiabetic Drug Sales Volume Market Share by Type (2013-2018)
Figure China Antidiabetic Drug Sales Volume Market Share by Type in 2017
Table China Antidiabetic Drug Sales Volume (K MT) by Application (2013-2018)
Table China Antidiabetic Drug Sales Volume Market Share by Application (2013-2018)
Figure China Antidiabetic Drug Sales Volume Market Share by Application in 2017
Figure Japan Antidiabetic Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Japan Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Antidiabetic Drug Sales Price (USD/MT) Trend (2013-2018)
Table Japan Antidiabetic Drug Sales Volume (K MT) by Players (2013-2018)
Table Japan Antidiabetic Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Antidiabetic Drug Sales Volume Market Share by Players in 2017
Table Japan Antidiabetic Drug Sales Volume (K MT) by Type (2013-2018)
Table Japan Antidiabetic Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Antidiabetic Drug Sales Volume Market Share by Type in 2017
Table Japan Antidiabetic Drug Sales Volume (K MT) by Application (2013-2018)
Table Japan Antidiabetic Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Antidiabetic Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Antidiabetic Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Southeast Asia Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Antidiabetic Drug Sales Price (USD/MT) Trend (2013-2018)
Table Southeast Asia Antidiabetic Drug Sales Volume (K MT) by Players (2013-2018)
Table Southeast Asia Antidiabetic Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Antidiabetic Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Antidiabetic Drug Sales Volume (K MT) by Type (2013-2018)
Table Southeast Asia Antidiabetic Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Antidiabetic Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Antidiabetic Drug Sales Volume (K MT) by Application (2013-2018)
Table Southeast Asia Antidiabetic Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Antidiabetic Drug Sales Volume Market Share by Application in 2017
Figure India Antidiabetic Drug Sales (K MT) and Growth Rate (2013-2018)
Figure India Antidiabetic Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Antidiabetic Drug Sales Price (USD/MT) Trend (2013-2018)
Table India Antidiabetic Drug Sales Volume (K MT) by Players (2013-2018)
Table India Antidiabetic Drug Sales Volume Market Share by Players (2013-2018)
Figure India Antidiabetic Drug Sales Volume Market Share by Players in 2017
Table India Antidiabetic Drug Sales Volume (K MT) by Type (2013-2018)
Table India Antidiabetic Drug Sales Volume Market Share by Type (2013-2018)
Figure India Antidiabetic Drug Sales Volume Market Share by Type in 2017
Table India Antidiabetic Drug Sales Volume (K MT) by Application (2013-2018)
Table India Antidiabetic Drug Sales Volume Market Share by Application (2013-2018)
Figure India Antidiabetic Drug Sales Volume Market Share by Application in 2017
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Antidiabetic Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sanofi-Aventis Antidiabetic Drug Sales Growth Rate (2013-2018)
Figure Sanofi-Aventis Antidiabetic Drug Sales Global Market Share (2013-2018)
Figure Sanofi-Aventis Antidiabetic Drug Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Antidiabetic Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Eli Lilly Antidiabetic Drug Sales Growth Rate (2013-2018)
Figure Eli Lilly Antidiabetic Drug Sales Global Market Share (2013-2018)
Figure Eli Lilly Antidiabetic Drug Revenue Global Market Share (2013-2018)
Table Oramed Basic Information List
Table Oramed Antidiabetic Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Oramed Antidiabetic Drug Sales Growth Rate (2013-2018)
Figure Oramed Antidiabetic Drug Sales Global Market Share (2013-2018
Figure Oramed Antidiabetic Drug Revenue Global Market Share (2013-2018)
Table Takeda Basic Information List
Table Takeda Antidiabetic Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Takeda Antidiabetic Drug Sales Growth Rate (2013-2018)
Figure Takeda Antidiabetic Drug Sales Global Market Share (2013-2018)
Figure Takeda Antidiabetic Drug Revenue Global Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Antidiabetic Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Antidiabetic Drug Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Antidiabetic Drug Sales Global Market Share (2013-2018)
Figure Boehringer Ingelheim Antidiabetic Drug Revenue Global Market Share (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Antidiabetic Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Novo Nordisk Antidiabetic Drug Sales Growth Rate (2013-2018)
Figure Novo Nordisk Antidiabetic Drug Sales Global Market Share (2013-2018
Figure Novo Nordisk Antidiabetic Drug Revenue Global Market Share (2013-2018)
Table Halozyme Therapeutics Basic Information List
Table Halozyme Therapeutics Antidiabetic Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Halozyme Therapeutics Antidiabetic Drug Sales Growth Rate (2013-2018)
Figure Halozyme Therapeutics Antidiabetic Drug Sales Global Market Share (2013-2018)
Figure Halozyme Therapeutics Antidiabetic Drug Revenue Global Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Antidiabetic Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Antidiabetic Drug Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Antidiabetic Drug Sales Global Market Share (2013-2018
Figure Bristol-Myers Squibb Antidiabetic Drug Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Antidiabetic Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Pfizer Antidiabetic Drug Sales Growth Rate (2013-2018)
Figure Pfizer Antidiabetic Drug Sales Global Market Share (2013-2018)
Figure Pfizer Antidiabetic Drug Revenue Global Market Share (2013-2018)
Table Tonghua Dongbao Basic Information List
Table Tonghua Dongbao Antidiabetic Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Tonghua Dongbao Antidiabetic Drug Sales Growth Rate (2013-2018)
Figure Tonghua Dongbao Antidiabetic Drug Sales Global Market Share (2013-2018)
Figure Tonghua Dongbao Antidiabetic Drug Revenue Global Market Share (2013-2018)
Table Biocon Basic Information List
Table Wockhardt Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetic Drug
Figure Manufacturing Process Analysis of Antidiabetic Drug
Figure Antidiabetic Drug Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetic Drug Major Players in 2017
Table Major Buyers of Antidiabetic Drug
Table Distributors/Traders List
Figure Global Antidiabetic Drug Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure Global Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Antidiabetic Drug Price (USD/MT) and Trend Forecast (2018-2025)
Table Global Antidiabetic Drug Sales Volume (K MT) Forecast by Regions (2018-2025)
Figure Global Antidiabetic Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Antidiabetic Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Antidiabetic Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Antidiabetic Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Antidiabetic Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Antidiabetic Drug Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure United States Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Antidiabetic Drug Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure Europe Antidiabetic Drug Revenue and Growth Rate Forecast (2018-2025)
Figure China Antidiabetic Drug Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure China Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Antidiabetic Drug Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure Japan Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Antidiabetic Drug Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Antidiabetic Drug Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure India Antidiabetic Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Antidiabetic Drug Sales (K MT) Forecast by Type (2018-2025)
Figure Global Antidiabetic Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Antidiabetic Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Antidiabetic Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Antidiabetic Drug Price (USD/MT) Forecast by Type (2018-2025)
Table Global Antidiabetic Drug Sales (K MT) Forecast by Application (2018-2025)
Figure Global Antidiabetic Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources